ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles

Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0110122. doi: 10.1128/aac.01101-22. Epub 2022 Nov 14.

Abstract

We analyzed a cohort of Trichosporon asahii strains with different MICs of fluconazole and voriconazole and evaluated the presence of ERG11 mutations. ERG11 mutation conferring an amino acid change was found and its resistance potential was evaluated by cloning into Saccharomyces cerevisiae susceptible host strain. Transformants were not resistant to either fluconazole nor voriconazole. Our results suggest that ERG11 variants exist among T. asahii isolates, but are not responsible for resistance phenotypes.

Keywords: 14-alpha-demethylase; ERG11; Trichosporon asahii; antifungal resistance; mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology
  • Azoles* / pharmacology
  • Cytochrome P-450 Enzyme System* / genetics
  • Drug Resistance, Fungal / genetics
  • Fluconazole / pharmacology
  • Microbial Sensitivity Tests
  • Saccharomyces cerevisiae / genetics
  • Trichosporon* / genetics
  • Voriconazole / pharmacology

Substances

  • Antifungal Agents
  • Azoles
  • Cytochrome P-450 Enzyme System
  • Fluconazole
  • Voriconazole

Supplementary concepts

  • Trichosporon asahii